Evolving Role of Interventional Pulmonology in the Interdisciplinary Approach to the Staging and Management of Lung Cancer: Bronchoscopic Mediastinal Staging of Lung Cancer
Clinical Lung Cancer, ISSN: 1525-7304, Vol: 8, Issue: 2, Page: 110-115
2006
- 14Citations
- 18Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations14
- Citation Indexes14
- 14
- CrossRef5
- Captures18
- Readers18
- 18
Review Description
Mediastinal lymph node involvement is present in 26%–38% of patients with non–small-cell lung cancer at the time of diagnosis, and it is often the most significant factor in determining surgical resectability. Complete and accurate mediastinal staging of lung cancer is essential for determining prognosis and for guiding optimal treatment strategies. Computed tomography and positron emission tomography are the most widely used noninvasive means for mediastinal staging in lung cancer. However, based on their reported specificities, computed tomography and positron emission tomography findings should be verified by cytohistologic sampling. In recent decades, the technique of transbronchial needle aspiration (TBNA) has been developed, permitting the bronchoscopist to obtain cytohistologic material from the hilar and mediastinal lymph nodes adjacent to the tracheobronchial wall. The technique of TBNA has a great specificity, is safe and cost-effective compared with surgical methods, and can be performed during the initial diagnostic bronchoscopy. Transbronchial needle aspiration sensitivity is 76%–78% but is highly influenced by several factors. Endobronchial ultrasound has been proposed as a means for improving TBNA sensitivity. Recently, a new type of bronchoscope with a built-in convex ultrasound probe directly attached to the tip has been developed to guide TBNA under real-time imaging. Reports on this innovative technique reveal a sensitivity of 94%–95.7%, which is superior to the reported sensitivity of surgical methods. However, ultrasound-guided TBNA and traditional TBNA should be considered complementary techniques, because their integration is likely to become the optimal staging strategy for patients with lung cancer.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S1525730411704958; http://dx.doi.org/10.3816/clc.2006.n.038; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=33750165461&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/17026811; http://linkinghub.elsevier.com/retrieve/pii/S1525730411704958; http://cigjournals.metapress.com/index/10.3816/CLC.2006.n.038; http://api.elsevier.com/content/article/PII:S1525730411704958?httpAccept=text/xml; http://api.elsevier.com/content/article/PII:S1525730411704958?httpAccept=text/plain; https://linkinghub.elsevier.com/retrieve/pii/S1525730411704958; https://dx.doi.org/10.3816/clc.2006.n.038
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know